Press Releases

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease today announced that Takeda Pharmaceutical Company Limited ("Takeda") will join the CEOi as part of its effort to spur innovations in research and accelerate a means of prevention for Alzheimer’s and Dementia, building momentum behind the G8’s com

USAgainstAlzheimer’s Applauds New Alzheimer’s Research Funding through Accelerating Medicines Partnership (AMP)

USAgainstAlzheimer’s will seek to advance the research goals of AMP as a member of the initiative’s steering committee


USAgainstAlzheimer’s disappointed by failure of the Administration to recommend funding at levels needed to achieve national goal of stopping Alzheimer’s disease by 2025

USAgainstAlzheimer’s Calls on U.S. to Create Global Fund to Fight Alzheimer’s

The fund would be modeled after The Global Fund to Fight AIDS, and intended to supercharge innovative Alzheimer’s research

USAgainstAlzheimer’s Applauds Bi-Partisan Congressional Action to Increase Funding for Alzheimer’s Research and Other Initiatives

WASHINGTON, DC – USAgainstAlzheimer’s applauded leaders of the House and Senate Appropriations Committees for including a sizeable increase for key Alzheimer’s disease research, public health, and provider and public education initiatives within the FY 2014 omnibus appropriations package released last evening.


^ Back to Top